Yvon Bastien
Chairman at PainCeptor Pharma Corp.
Net worth: - $ as of 29/04/2024
Profile
Yvon Bastien currently works at PainCeptor Pharma Corp., as Chairman.
Mr. Bastien also formerly worked at Sanofi Canada, Inc., as Chief Executive Officer, Jouveinal Canada, as Chief Executive Officer, Telesta Therapeutics, Inc., as Chairman, Helix BioPharma Corp., as Chairman from 2014 to 2016, Trillium Health Care Products, Inc., as Chairman, Enobia Pharma, Inc., as Chairman, St. Bernard Soap Co., as Chairman, HLS Therapeutics, Inc., as Independent Director, and HLS Therapeutics, Inc., as Independent Director.
Mr. Bastien received his Masters Business Admin degree from Sir George Williams University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
-.--% | 11/12/2022 | 0 ( -.--% ) | - $ | 29/04/2024 |
Yvon Bastien active positions
| Companies | Position | Start |
|---|---|---|
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Chairman | - |
Former positions of Yvon Bastien
| Companies | Position | End |
|---|---|---|
| HELIX BIOPHARMA CORP. | Chairman | 17/01/2016 |
| Jouveinal Canada | Chief Executive Officer | - |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Chief Executive Officer | - |
| HLS THERAPEUTICS INC. | Director/Board Member | - |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Director/Board Member | - |
Training of Yvon Bastien
| Sir George Williams University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HELIX BIOPHARMA CORP. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private companies | 8 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Trillium Health Care Products, Inc.
 Trillium Health Care Products, Inc. Pharmaceuticals: MajorHealth Technology Trillium Health Care Products, Inc. manufactures pharmaceutical and health care products. The firm offers over-the-counter and prescription pharmaceutical products in solid, semi-solid, and liquid dosage forms for market segments, including pain and inflammation, gastro-intestinal, cold and flu, allergy, dermatology, oral care, and nutrition. The company was founded in 1993 and is headquartered in Brockville, Canada. | Health Technology |
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Health Technology |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
| Jouveinal Canada | |
St. Bernard Soap Co.
 St. Bernard Soap Co. Household/Personal CareConsumer Non-Durables Part of Trillium Health Care Products, Inc., St. Bernard Soap Co. is a company that manufactures and sells bar soaps. The company is based in Cincinnati, OH. | Consumer Non-Durables |
- Stock Market
- Insiders
- Yvon Bastien
